StockData
Transcode Therapeutics, Inc. logo

Transcode Therapeutics, Inc. (RNAZ) stock

RNAZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.34−0.06 (-4.61%)

Close on Nov 18, 2026Market cap $1.36MP/E –Yield –

Transcode Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Transcode Therapeutics's price to book ratio was 3.3× on Jul 31, 2026, against 25.2× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 20263.3×−0.7
2025Dec 31, 20254.0×−323.9
2024Jul 31, 2024327.9×–

More Transcode Therapeutics figures

See a number that looks wrong?